contact us to

get started

Contact Sales
banner
On-Demand Webinar

340B: Issues and Opportunities for Pharma Manufacturers

Join Model N for a robust review of the most pressing concerns the industry faces regarding the 340B program.

340B is one of the most significant revenue leakage challenges impacting pharmaceutical manufacturers. While the 340B program has grown tremendously, issues ranging from duplicate discounts to diversion creates complex issues manufacturers must address to mitigate revenue loss. Join Model N for a robust review of the most pressing concerns the industry faces regarding the 340B program.

You might also like

340b-cover
Whitepaper
Whitepaper
Whitepaper
Best practices for complying with 340B
Read this white paper to learn how you can improve the chargeback process, generate an audit trail, and ensure correct 340B pricing. VIEW Whitepaper
2021-state-of-revenue-report-resources-thumbnail
Whitepaper
Whitepaper
Whitepaper
2021 State of Revenue Report
Discover how executives are dealing with today’s challenges and where they think the biggest opportunities lie. VIEW Whitepaper
Case Study
Case Study
Case Study
Keryx Biopharmaceuticals Case Study
Keryx, is a rapidly growing biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products geared towards addressing unmet needs and providing unique and meaningful... VIEW Case Study

Start typing and press Enter to search